UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: October 21, 2022 5:00 P.M.
Form: S-3
CIK: 0000882361
Company Name: Aptose Biosciences Inc.
File Number: 333-267801